Union MoS for Health and Family Welfare Smt. Anupriya Patel launches 7th National Formulary of India 2026, announces Biovigilance Programme to widen India’s patient-safety net
Union Minister of State Smt. Anupriya Patel launched the 7th Edition of the National Formulary of India (NFI) 2026, the Guidance Document for Hospitals on medical device safety, and the ADR-PvPI 2.0 Mobile App for iOS users. She also announced the government approval of the Biovigilance Programme of India during the 6th National Pharmacovigilance Week. India's global ranking in contributions to the WHO patient safety database has risen to 8th position.
In Simple Words
Union Minister of State Smt. Anupriya Patel launched the 7th Edition of the National Formulary of India (NFI) 2026, along with safety guidelines for hospitals and the ADR-PvPI 2.0 Mobile App for iOS users, during the 6th National Pharmacovigilance Week. She also announced the approval of the Biovigilance Programme of India to monitor adverse events related to biological products in organ and tissue transplantation.
India has advanced from the 123rd position to 8th globally in contributions to the WHO patient safety database. The newly launched NFI 2026 features 34 chapters, 20 appendices, and 653 drugs. Additionally, digital platforms like NFI Online and approximately 1,150 adverse drug reaction reporting centres are helping strengthen medicine safety and patient care across the country.
Key Points
- Smt. Anupriya Patel launched the 7th Edition of the National Formulary of India (NFI) 2026.
- The 6th National Pharmacovigilance Week is observed from 17-23 September 2026.
- The theme for the 6th National Pharmacovigilance Week is "Promoting Rational Use of Medicines through Pharmacovigilance: A Step Towards Safer Healthcare."
- India rose from the 123rd position during 2009-2014 to 8th globally in contributions to the WHO patient safety database.
- The Government of India approved the Biovigilance Programme of India.
- The NFI 2026 comprises 34 chapters, 20 appendices, and 653 drugs, including 42 fixed-dose combinations and 30 immunologicals.
- Around 25 countries recognize and accept the Indian Pharmacopoeia.
- There are approximately 1,150 operational ADR reporting centres across public and private hospitals, medical colleges, and medical-device vigilance facilities in the country.
Exam Angle
A. 7th Edition
Source: Press Information Bureau